Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2012 | 08-2011 | 08-2010 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,069 | 21,911 | N/A | N/A | N/A |
| Marketable Securities | 33,565 | N/A | N/A | N/A | N/A |
| Receivables | 765 | 1,292 | N/A | N/A | N/A |
| Inventories | 841 | N/A | N/A | N/A | N/A |
| Other current assets | 278 | 3,000 | 0 | 0 | 0 |
| TOTAL | $57,568 | $26,834 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,756 | 6,780 | N/A | N/A | N/A |
| Investments And Advances | 5,720 | 3,000 | 0 | 0 | 0 |
| Other Non-Current Assets | 203 | 183 | 0 | 0 | 0 |
| TOTAL | $11,679 | $9,963 | $N/A | $N/A | $N/A |
| Total Assets | $69,247 | $36,797 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 134 | 2,168 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,476 | 6,972 | 0 | 0 | 0 |
| Other current liabilities | 31 | 31 | N/A | N/A | N/A |
| TOTAL | $6,342 | $10,095 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 256 | 2,013 | N/A | N/A | N/A |
| Deferred Revenues | 701 | 924 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 88 | 31,505 | 0 | 0 | 0 |
| TOTAL | $344 | $33,518 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,686 | $43,613 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,100 | N/A | N/A | N/A | N/A |
| Common Shares | 245 | 20 | N/A | N/A | N/A |
| Retained earnings | -242,073 | -212,663 | N/A | N/A | N/A |
| Other shareholders' equity | -283 | 197,475 | 0 | 0 | 0 |
| TOTAL | $62,561 | $-6,816 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $69,247 | $36,797 | $0 | $0 | $0 |